封面
市場調查報告書
商品編碼
1789390

顯影劑

Contrast Media Market, By Type, By Imaging Technique, By Application, By Route of Administration, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

顯影劑市場規模預計在 2025 年為 63.5 億美元,預計到 2032 年將達到 109.5 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 8.1%。

分析範圍 分析詳細資訊
基準年 2024 市場規模(2025年) 63.5億美元
效能數據 2020-2024 預測期 2025-2032
預測期間的複合年成長率(2025-2032年) 8.10% 預計金額(2032年) 109.5億美元

全球顯影劑市場是醫學影像產業的重要組成部分,涵蓋旨在增強診斷影像過程中體內結構可見度的專用藥劑。這些顯影劑(也稱為造影染料)用於患者接受各種影像檢查,包括電腦斷層掃描 (CT)、超音波磁振造影(MRI)、超音波和 X 光,以提高診斷準確性和臨床療效。

市面上的顯影劑種類繁多,包括碘基顯影劑、钆基顯影劑、鋇基化合物和微氣泡造影顯影劑,每種造影劑都是針對特定的成像應用和患者要求量身定做的。由於慢性病的增加、人口老化以及醫學影像設備的技術進步,全球對先進顯影劑解決方案的需求持續成長。在提高診斷準確性同時最大限度地減少副作用的需求的推動下,市場的特點是配方化學、安全性和有針對性的成像應用不斷創新。市場參與企業正專注於開發具有改進的生物相容性、降低的腎毒性和增強的影像處理能力的下一代顯影劑,以滿足全球不同醫療環境中不斷變化的臨床需求和監管標準。

市場動態

全球顯影劑市場的成長受到若干關鍵因素的驅動,這些因素推動了國際醫療保健體系的持續成長。心血管、癌症和神經系統疾病的盛行率不斷上升,對先進的診斷影像技術提出了更高的要求,從而推動了對能夠精確顯示解剖結構和病理的高品質顯影劑的需求。醫療影像設備的技術進步,例如高解析度CT掃描儀、先進的MRI系統和高性能超音波設備的開發,為增強顯影劑創造了機會,使其能夠充分利用改進的診斷成像能力。

全球人口老化是主要的成長動力,因為老年患者需要更頻繁地進行影像學檢查以管理慢性病和預防性醫療保健/篩檢計畫。然而,市場面臨重大限制因素,例如嚴格的監管核准流程,這延遲了產品上市並增加了開發成本,尤其是對於需要大量臨床試驗和安全評估的新型顯影劑配方。由於擔心某些顯影劑會引起顯影劑誘發的腎臟病、過敏反應和腎源性系統性纖維化等安全問題,醫療專業人員和患者對某些造影劑的採用模式持謹慎態度,對市場擴張構成了挑戰。儘管存在這些限制因素,但新興經濟體醫療基礎設施的擴大、醫療支出的增加、早期疾病檢測意識的提高以及提供有針對性成像解決方案的器官特異性顯影劑的開發,正在湧現出巨大的商機。

本報告的主要特點

  • 本報告對全球顯影劑市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它還強調了每個領域的潛在商機,並描述了該市場的一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球顯影劑市場的主要企業已根據以下參數進行分析,例如公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 「全球顯影劑市場」報告涉及該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球顯影劑市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 抑制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特五力分析
  • 企業合併(M&A)場景
  • 產業趨勢

第4章。全球顯影劑市場按類型(以金額為準,2020-2032)

  • 碘基顯影劑
  • 單體碘顯影劑
  • 二聚碘顯影劑
  • 钆基顯影劑(GBCM)
  • 鋇基顯影劑
  • 其他(微氣泡顯影劑)

5. 全球顯影劑(以金額為準,2020-2032 年)

  • X光/電腦斷層掃描(CT)
  • 磁振造影(MRI)
  • 超音波影像
  • 透視
  • 其他(血管造影術)

6. 全球顯影劑市場應用(以金額為準,2020-2032)

  • 心血管系統
  • 腫瘤學
  • 神經病學
  • 胃腸道
  • 肌肉骨骼
  • 泌尿系統
  • 感染疾病
  • 其他治療領域

7. 依給藥途徑分類的全球顯影劑市場(以金額為準,2020-2032 年)

  • 口服
  • 直腸
  • 靜脈

8. 全球顯影劑(以金額為準,2020-2032)

  • 醫院
  • 診斷中心
  • 影像中心
  • 門診手術中心
  • 其他(研究和學術機構)

9. 全球顯影劑市場按地區(以金額為準,2020-2032)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第10章 競爭格局

  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN(Medtronic)
  • Esaote SpA
  • Shimadzu Corporation
  • Hughes Medical Systems

第 11 章分析師建議

  • “命運之輪”
  • 分析師觀點
  • Coherent Opportunity Map (COM)

第12章參考文獻與調查方法

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI8350

Contrast Media Market is estimated to be valued at USD 6.35 Bn in 2025 and is expected to reach USD 10.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.35 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.10% 2032 Value Projection: USD 10.95 Bn

The global contrast media market represents a critical segment within the broader medical imaging industry, encompassing specialized pharmaceutical agents designed to enhance the visibility of internal body structures during diagnostic imaging procedures. These contrast agents, also known as contrast materials or contrast dyes, are administered to patients undergoing various imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray examinations to improve diagnostic accuracy and clinical outcomes.

The market comprises different types of contrast media, including iodinated contrast agents, gadolinium-based contrast agents, barium-based compounds, and microbubble contrast agents, each tailored for specific imaging applications and patient requirements. With the increasing prevalence of chronic diseases, aging population demographics, and technological advancements in medical imaging equipment, the demand for sophisticated contrast media solutions continues to expand globally. The market is characterized by continuous innovation in formulation chemistry, safety profiles, and targeted imaging applications, driven by the need for enhanced diagnostic precision while minimizing adverse reactions. Key market participants focus on developing next-generation contrast agents with improved biocompatibility, reduced nephrotoxicity, and enhanced imaging capabilities to meet evolving clinical demands and regulatory standards across diverse healthcare settings worldwide.

Market Dynamics

The global contrast media market growth is primarily driven by several key factors that collectively fuel its sustained growth trajectory across international healthcare systems. The increasing incidence of cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic imaging procedures, thereby boosting demand for high-quality contrast agents that enable precise visualization of anatomical structures and pathological conditions. Technological advancements in medical imaging equipment, including the development of high-resolution CT scanners, advanced MRI systems, and sophisticated ultrasound devices, create opportunities for enhanced contrast media formulations that can capitalize on improved imaging capabilities.

The aging global population represents a significant growth driver, as elderly patients require more frequent diagnostic imaging procedures for chronic disease management and preventive healthcare screening programs. However, the market faces notable restraints including stringent regulatory approval processes that can delay product launches and increase development costs, particularly for novel contrast agent formulations requiring extensive clinical trials and safety evaluations. Safety concerns related to contrast-induced nephropathy, allergic reactions, and nephrogenic systemic fibrosis associated with certain contrast agents pose challenges for market expansion, leading to cautious adoption patterns among healthcare providers and patients. Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, growing awareness about early disease detection, and the development of organ-specific contrast agents that offer targeted imaging solutions.

Key Features of the Study

  • This report provides an in-depth analysis of the global contrast media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global contrast media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Bayer AG, Bracco Imaging, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, Guerbet Group, Mallinckrodt Pharmaceuticals, Canon Medical Systems, Hologic, Inc., Lantheus Medical Imaging, COVIDIEN (Medtronic), Esaote S.p.A., Shimadzu Corporation, and Hughes Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contrast media market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Iodinated Contrast Media
    • Monomeric Iodinated Contrast Media
    • Dimeric Iodinated Contrast Media
    • Gadolinium-Based Contrast Media (GBCM)
    • Barium-Based Contrast Media
    • Others (Microbubble Contrast Media)
  • Imaging Technique Insights (Revenue, USD Bn, 2020 - 2032)
    • X-ray/Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound Imaging
    • Fluoroscopy
    • Others (Angiography)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cardiovascular
    • Oncology
    • Neurology
    • Gastrointestinal
    • Musculoskeletal
    • Pulmonary
    • Urology
    • Infectious Diseases
    • Other Therapeutic Areas
  • Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Rectal
    • Intravenous
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Imaging Centers
    • Ambulatory Surgical Centers
    • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Bayer AG
    • Bracco Imaging
    • Siemens Healthineers
    • Fujifilm Holdings Corporation
    • Philips Healthcare
    • Guerbet Group
    • Mallinckrodt Pharmaceuticals
    • Canon Medical Systems
    • Hologic, Inc.
    • Lantheus Medical Imaging
    • COVIDIEN (Medtronic)
    • Esaote S.p.A.
    • Shimadzu Corporation
    • Hughes Medical Systems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contrast Media Market, By Type
    • Global Contrast Media Market, By Imaging Technique
    • Global Contrast Media Market, By Application
    • Global Contrast Media Market, By Route of Administration
    • Global Contrast Media Market, By End User
    • Global Contrast Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contrast Media Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Monomeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dimeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gadolinium-Based Contrast Media (GBCM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Barium-Based Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Microbubble Contrast Media)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contrast Media Market, By Imaging Technique, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • X-ray/Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ultrasound Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fluoroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Angiography)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contrast Media Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contrast Media Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Contrast Media Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Contrast Media Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bracco Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Guerbet Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • COVIDIEN (Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Esaote S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hughes Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us